Drug intelligence / Profile preview

Folvitra

Development stage
Unknown
Lead developer
Blue Heron Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Folvitra is a nutritional supplement, often categorized as a medical food, developed by Blue Heron Pharmaceuticals for the dietary management of patients with folate deficiency and for prenatal nutritional support. It is formulated with a combination of bioactive B-vitamins in their active forms: L-methylfolate (as L-methylfolate calcium), Vitamin B12 (as methylcobalamin), and Vitamin B6 (as pyridoxal 5-phosphate). These specific forms are utilized to ensure high bioavailability and to bypass the enzymatic conversion steps required by synthetic vitamins, which is particularly beneficial for individuals with genetic polymorphisms such as those affecting the methylenetetrahydrofolate reductase (MTHFR) enzyme. Folvitra supports the methylation cycle, aids in the reduction of homocysteine levels, and provides essential nutrients for DNA synthesis and neural development.

Brand names
Folvitra
02

Targets

MTR (Methionine synthase)FOLR1 (FRα)CBS (Cystathionine beta-synthase)

Beyond the preview

Go deeper on Folvitra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folvitra.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call